Patents Assigned to Compagnie ORIS Industrie S.A.
  • Patent number: 5217905
    Abstract: A device for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid.This device comprises a first reaction zone in which there is an at least temporarily impermeable membrane designed to receive a sample of test fluid and to be associated with at least one labeled reagent; a second reaction zone which is bounded on the one hand by the said membrane and on the other by a second at least temporarily impermeable membrane comprising a solid phase containing a reference reagent; and a third reaction zone which contains means for developing the reaction.A method for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid.Applications to the detection of the presence, in a biological fluid, of antibodies or antigens in particular.
    Type: Grant
    Filed: July 18, 1988
    Date of Patent: June 8, 1993
    Assignees: Compagnie Oris Industrie S.A., Cistest
    Inventors: Joseph Marchand, Jacques Toledano
  • Patent number: 5010017
    Abstract: The invention relates to a process for the immunological quantitative determination of the T.sub.3 and/or T.sub.4 thyroid hormones.In a process for the immunological quantitative determination of T.sub.4 thyroxine and/or T.sub.3 triiodothyronine present in free form in a sample, T.sub.3 and/or T.sub.4 to be determined are put into competition with thyroglobulin for the sites of anti-T.sub.3 and/or anti-T.sub.4 antibodies present in a limited quantity, whereafter a determination is made of either the quantity of thyroglobulin fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies, or the quantity of thyroglobulin not fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies.Application to the determination of the total T.sub.3 and/or T.sub.4 of a biological sample.
    Type: Grant
    Filed: August 17, 1990
    Date of Patent: April 23, 1991
    Assignee: Compagnie Oris Industrie S.A.
    Inventors: Bernard Ferrua, Claude Moulin
  • Patent number: 4966838
    Abstract: The invention relates to a process for the immunological quantitative determination of the T.sub.3 and/or T.sub.4 thyroid hormones.In a process for the immunological quantitative determination of T.sub.4 thyroxine and/or T.sub.3 triiodothyronine present in free form in a sample, T.sub.3 and/or T.sub.4 to be determined are put into completion with thyroglobulin for the sites of anti-T.sub.3 and/or anti-T.sub.4 antibodies present in a limited quantity, whereafter a determination is made of either the quantity of thyroglobulin fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies, or the quantity of thyroglobulin not fixed to the anti-T.sub.3 and/or anbti-T.sub.4 antibodies.
    Type: Grant
    Filed: May 11, 1987
    Date of Patent: October 30, 1990
    Assignee: Compagnie Oris Industrie S.A.
    Inventors: Bernard Ferrua, Claude Moulin
  • Patent number: 4888019
    Abstract: A polymer articular prosthesis having a sliding surface, wherein the latter is constituted by a thin layer of said polymer grafted with tetrafluoro-ethylene.The process for preparing the articular prosthesis comprises coating with a protective varnish the outer surface of a polymer articular prosthesis having a sliding surface, except in the areas constituting this sliding surface irradiating the prosthesis with ionizing rays, contacting the prosthesis with the tetrafluoroethylene vapour for adequate time to bring about tetrafluoroethylene grafting over a limited thickness of the polymer forming the sliding surface and then removing the protective varnish.
    Type: Grant
    Filed: September 9, 1982
    Date of Patent: December 19, 1989
    Assignee: Compagnie Oris Industrie S.A.
    Inventors: Gilbert Gauneus, Maryvonne Nicaise, Kifu O. Tran
  • Patent number: 4729904
    Abstract: Inert cross-linked copolymer able to absorb and then progressively release a pharmaceutically active substance, wherein it is constituted by a powder of a cross-linked copolymer comprising30 to 80% by weight of monounsaturated alkyl acrylate and/or methacrylate;5 to 68% by weight of acrylic and/or methacrylic acid; and2 to 15% by weight of bifunctional or trifunctional acrylate and/or methacrylate.A mixture of monounsaturated alkyl acrylate and/or methacrylate, acrylic and/or methacrylic acid, and bifunctional or trifunctional acrylate and/or methacrylate monomers is polymerized in accordance with a free radical polymerization mechanism.The support is used for the preparation of a delayed action or release medicament.
    Type: Grant
    Filed: August 7, 1985
    Date of Patent: March 8, 1988
    Assignee: Compagnie ORIS Industrie S.A.
    Inventors: Jeanne Berthet, Marie-Francoise Blin, Gilbert Gaussens
  • Patent number: 4590068
    Abstract: Inert cross-linked copolymer able to absorb and then progressively release a pharmaceutically active substance, wherein it is constituted by a powder of a cross-linked copolymer comprising30 to 80% by weight of monounsaturated alkyl acrylate and/or methacrylate;5 to 68% by weight of acrylic and/or methacrylic acid; and2 to 15% by weight of bifunctional or trifunctional acrylate and/or methacrylate polymerized in accordance with free radical polymerization mechanisms.
    Type: Grant
    Filed: August 22, 1983
    Date of Patent: May 20, 1986
    Assignee: Compagnie ORIS Industrie S.A.
    Inventors: Jeanne Berthet, Marie-Francoise Blin, Gilbert Gaussens